Twist Bioscience Corporation (NASDAQ:TWST) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Twist Bioscience's Fiscal 2023 Second Quarter Financial Results Conference Call.
Twist Bioscience Corp (TWST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 7,179,112 | $108,261,009 | +8% | 0.74% |
| 2. | Citadel Investment Group Ken Griffin | 1,173,828 | $17,701,326 | +108% | 0% |
| 3. | Avidity Partners Management David Witzke And Michael Gregory | 819,000 | $12,350,520 | +35% | 0.4% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 714,528 | $10,775,082 | +204% | 0.02% |
| 5. | Casdin Capital Eli Casdin | 700,000 | $10,556,000 | -26% | 0.86% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.20 | 10,000 | 29,297 | 2023-05-10 | Filing | ||
| $29.25 | 8,550 | 13,939 | 2022-05-11 | Filing | ||
| $14.00 | 60,000 | Large Shareholder, Director | 954,146 | 2018-11-02 | Filing | |
| $14.00 | 15,000 | Large Shareholder, Director | 2,407,422 | 2018-11-02 | Filing | |
| $14.00 | 60,000 | Large Shareholder | 954,146 | 2018-11-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.46 | 1,732 | 11,340 | 2023-02-09 | Filing | ||
| $26.46 | 1,732 | 11,616 | 2023-02-09 | Filing | ||
| $24.05 | 292 | 272,614 | 2023-01-04 | Filing | ||
| $24.90 | 1,275 | 253,631 | 2022-11-21 | Filing | ||
| $29.55 | 379 | 255,581 | 2022-10-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 6,213,441 | $93,698,690 | 0% | |
| 2. | 5,697,547 | $85,919,010 | 0% | |
| 3. | 5,275,841 | $79,559,682 | 0% | |
| 4. | 4,057,312 | $61,185,000 | 0.03% | |
| 5. | 3,401,914 | $51,300,863 | 0.03% |
News See All
12 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 12 gene editing stocks with the best long-term potential.
Top 10 CRISPR Stocks To Buy
Molecular biology, genetics, and genomics are in a significant period in history where technical capabilities and methods enable the editing of specific DNA segments and base pairs in living organisms...
11 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 11 most promising gene editing stocks according to analysts.
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2023 Earnings Call Transcript
Operator: Welcome to Twist Bioscience's Fiscal 2023 First Quarter Financial Results Conference Call. .
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Twist Bioscience Fiscal 2022 Fourth Quarter and Year-end Financial Results Conference Call.
Is Twist Bioscience Corporation (TWST) a Worthy Long-Term Investment?
Jackson Square Partners, an investment management firm, released its “SMID-Cap Growth” Q3 2022 investor letter. A copy of the same can be downloaded here.
4 Cheap Stocks to Buy According to Cathie Wood
ARK increased its holding in Twist Bioscience by 7% in the third quarter of this year, ending the period with 6.8 million shares of the company, worth $235.3 million.
10 Cathie Wood Stocks to Buy Before the Bull Run Starts
In this article, we discuss 10 Cathie Wood stocks to buy before the bull run starts.
10 Healthcare Stocks Making Moves After Earnings
In this article, we will take a look at the 10 healthcare stocks making moves after earnings.
Billionaire Hedge Funds
